3Susan MM. Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy[ J]. J Asthma Allergy, 2012,2012(5) :51 -59.
4Zuberbier T. A Summary of the new international EAAC1/GALEN/EDF/ WAO guiddines in urticaria[J]. World Allergy Organ J,2012 ,5(1) :1 -5.
5KimM, MaengJ, LeeK. Dimerization of TCTP and its clinical implica- tions for allergy [ J ]. Biochimie,2013,95 (4) :659 - 666.
6Yuko Kawakanfi, Toshiaki Kawakami, Jun-ichi Kashiwakura, et al. Most highly cytokinergic lgEs have polyreactivity to autoantigens[ J ]. Allergy Asthma lmmunol Res,2012,4(6) :332 -340.
7Ando T,Kashiwakura J, Kawakami Y, et al. Histamine releasing factor (HRF) in asthma and atopic dermatitis[ J ]. J Immunol,2012,188 : 177.
8Lee HS, Park CS, Lee YM, et al. Antigen-induced Ca2 mobilization in RBL-2H3 cells: role of I ( 1,4, 5) P3 and S1P and necessity of I (1,4,5)P3 production [J]. Cell Cal- cium, 2005,38(6) : 581.
9Oppong E, Flink N, Cato AC.Molecular mechanisms of glucocorticoid action in mast cells[J]. Mol Cell Endocri- nol, 2013,380(1/2) : 119.
10Parravicini V, Gadina M, Kovarova M, et al. Fyn kinase initiates complementary signals required for IgE-depen- dent mast cell degranulation[J]. Nat Immunol, 2002,3 (8) : 741.
